发明名称 |
PHARMACEUTICAL COMPOSITIONS CONTAINING FURAN DERIVATIVES |
摘要 |
The invention relates to a pharmaceutical composition in solid unit dosage form adapted for oral administration, comprising a salt formed between ranitidine and a complex of bismuth with a carboxylic acid selected from tartaric acid and citric acid together with an alkaline salt. For example the composition is in tablet form and comprises ranitidine bismuth citrate and sodium carbonate. The composition shows improved disintegration and/or dissolution.
|
申请公布号 |
CA2050970(A1) |
申请公布日期 |
1992.03.12 |
申请号 |
CA19912050970 |
申请日期 |
1991.09.09 |
申请人 |
GLAXO GROUP LIMITED |
发明人 |
SMITH, NORMAN R.;HEPPENSTALL, COLIN R.;DOUGLAS, STEPHEN J. |
分类号 |
A61K31/341;A61K;A61K9/20;A61K31/29;A61K31/34;A61K31/345;A61K31/445;A61K31/47;A61K33/00;A61K33/24;A61K47/06;A61P1/00;A61P1/04;(IPC1-7):A61K31/555 |
主分类号 |
A61K31/341 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|